Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
heart attack
Pharma
Amgen's Repatha meets the mark in CV primary prevention trial
On the heels of a label expansion in August, Amgen is touting another potential avenue to extend the value of its aging PCSK9 cholesterol med Repatha.
Fraiser Kansteiner
Oct 2, 2025 11:26am
Amgen tackles dangers of LDL cholesterol in 1st documentary film
Jul 9, 2025 7:55am
FDA approves Roche's heart attack med TNKase to treat stroke
Mar 3, 2025 3:19pm
Streisand nonprofit runs PSA to educate women about heart health
Feb 2, 2024 9:20am
ACC: Lexicon's sotagliflozin can cut stroke, heart attack
Apr 2, 2022 3:37pm
Sandoz recalls solo lot of enoxaparin over shipping glitch
Dec 3, 2021 12:24pm